Objectives: Hypertension and diabetes mellitus (DM) are the leading causes of cardiovascular, cerebrovascular, and chronic kidney diseases. They affect an estimated 47% and 11% of Americans, respectively. In this study, we assessed whether a dedicated patient navigator embedded within a patient-centered medical home (PCMH) using a structured panel management and...
Objectives: The aims of this study were to describe the baseline estimated blood loss (EBL) in surgery and transfusion rate in patients undergoing cytoreductive surgeries for ovarian malignancy, and identify perioperative variables associated with blood loss and transfusion. Methods: A retrospective cohort study at a single institution was performed that...
Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of liver disease without ongoing or significant alcohol use that ranges from hepatic steatosis to cirrhosis. NAFLD is associated with obesity, insulin resistance, type 2 diabetes mellitus (T2DM), hypertension, and dyslipidemia.1,2 Nonalcoholic steatohepatitis (NASH) represents the progression of NAFLD with at least...
Objectives: Eradication of Helicobacter pylori reduces the risk of gastric cancer (GC). Individuals with type 2 diabetes mellitus (T2DM) are known to be at increased risk for GC. In a cohort of H. pylori-positive individuals, we assessed whether those with T2DM were at risk of persistent infection following H. pylori...
We present a case of a patient who underwent cardiac arrest in the immediate postpartum period secondary to an avulsion of the right ovarian vein from the inferior vena cava (IVC).
Usher Syndrome is a genetically inherited condition characterized by congenital sensorineural hearing loss as well as progressive vision loss secondary to retinitis pigmentosa.
Coronavirus disease 2019 (COVID-19) has played a significant part in systematic damage, affecting lives and leading to significant mortality. The endocrine system is one of the systems affected by this pandemic outbreak. The relationship between them has been identified in previous and ongoing research. The mechanism through which severe acute...
Objectives: The use and overall benefit of glucagon-like peptide-1 (GLP-1) receptor agonist therapy for hospitalized patients with type 2 diabetes mellitus (DM) with chronic kidney disease (CKD) has limited data regarding impact and safety. We studied the impact and safety of GLP-1 receptor agonist therapy in hospitalized DM patients with...
Membership grants access to journals, courses and a slew of premium benefits.
Please consider supporting us by choosing an option below:
View Membership Options Make A Tax-Deductable Donation
No Thanks, take me to the site and don't show me this again.